Furthermore, the downregulation of HLA-DRB1 is not only associated with metastasis and poor prognosis of CM patients, but also might accelerate the change of TME from tumor suppressive to tumor friendly. The gene discussed is HLA-DRB1; the disease is cutaneous mastocytosis.